1 - 25 of 75 Items

Review paper2023, mar 21

Review of current status of targeted alpha therapy in cancer treatment

Tania Jabbar, Sajid Bashir, Muhammad Imran Babar

Vol 26 (2023): Continuous Publishing

Review paper

Pubmed: 38966955
Nucl. Med. Rev 2023;26:54-67.
Research paper2022, jul 12

Increased physiological [18F]FDG uptake in the liver and blood pool among patients with impaired renal function

Yoichi Otomi, Yuta Arai, Maki Otomo, Saho Irahara, Kaori Terazawa, Michiko Kubo, Takashi Abe, Takayoshi Shinya, Hideki Otsuka, Masafumi Harada

Vol 25, No 2 (2022)

Research paper

Pubmed: 35848547
Nucl. Med. Rev 2022;25(2):95-100.
Research paper2022, jun 21

[18F]FDG PET/CT and CA-125 in the evaluation of ovarian cancer relapse or persistence: is there any correlation?

Francesco Dondi, Domenico Albano, Francesco Bertagna, Raffaele Giubbini

Vol 25, No 2 (2022)

Research paper

Pubmed: 35848529
Nucl. Med. Rev 2022;25(2):78-84.
Research paper2022, sep 13
Research paper2022, jan 18
Research paper2022, jan 27

The efficacy of melatonin against radiotoxicity of iodine-131 and its response to treatment in hyperthyroid patients: a randomized controlled trial

Soudabe Alidadi, Ali Shabestani Monfared, Mehrangiz Amiri, Ebrahim Zabihi, Ehsan Assadollahi, Amir Gholami, Zoleika Moazezi, Zeinab Abedian

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137935
Nucl. Med. Rev 2022;25(1):31-36.
Research paper2022, jan 26

Detection of a second primary cancer in a 18F-fluorocholine PET/CT – multicentre retrospective analysis on a group of 1345 prostate cancer patients

Paulina Cegla, Katarzyna Scibisz-Dziedzic, Kamila Witkowska, Anna Kubiak, Ewa Wierzchoslawska, Witold Kycler, Beata Chrapko, Rafał Czepczyński

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137934
Nucl. Med. Rev 2022;25(1):25-30.
Research paper2022, jan 31

Hepatic complications of peptide receptor radionuclide therapy with Lutetium-177 and Yttrium-90 in patients with neuroendocrine neoplasm

Barbara Bober, Marek Saracyn, Arkadiusz Lubas, Maciej Kolodziej, Dorota Brodowska-Kania, Waldemar Kapusta, Grzegorz Kaminski

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137938
Nucl. Med. Rev 2022;25(1):54-61.
Research paper2023, feb 16
Research paper2022, jan 31

Relationship between cerebral blood flow reduction patterns on scintigraphy and nonmotor symptoms in new-onset Lewy body disease

Yukinori Okada, Makoto Shiraishi, Koji Hori, Keiichro Yamaguchi, Yasuhiro Hasegawa

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137933
Nucl. Med. Rev 2022;25(1):18-24.
Review paper2023, jul 11

Diagnosis and treatment of lung cancer using nuclear medicine techniques — current state of the art

Paulina Cegla, Agnieszka Bos-Liedke, Ewa Burchardt, Ewelina Konstanty, Adam Piotrowski, Maciej Kozak, Witold Cholewinski

Vol 26 (2023): Continuous Publishing

Review paper

Pubmed: 38966956
Nucl. Med. Rev 2023;26:77-84.
Research paper2022, jul 11

Optimal timing of SPECT/CT to demonstrate parathyroid adenomas in 99mTc-sestamibi scintigraphy

Kate Hunter, Niamh Gavin, Colin McQuade, Brendan Hogan, John Feeney

Vol 25, No 2 (2022)

Research paper

Pubmed: 36047295
Nucl. Med. Rev 2022;25(2):89-94.
Research paper2022, jun 27

Sensitivity and specificity of nuclear medicines (DTPA and DMSA) with magnetic resonance imaging in diagnosing bone metastasis

Shoaa G. Shetewi, Jaber Alyami, Bander S. Al Mutairi, Saeed M. Bafaraj

Vol 25, No 2 (2022)

Research paper

Pubmed: 35848548
Nucl. Med. Rev 2022;25(2):85-88.
Clinical vignette2022, jun 21

Amino acid extravasation: a rare red flag to keep in mind during peptide receptor radioligand therapy (PRRT) with [177Lu]Lu-DOTATATE

Ghasemali Divband, Seyed Hootan Alavi, Zohre Adinehpour, Forough Kalantari, Soroush Zarehparvar Moghadam

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 35848524
Nucl. Med. Rev 2022;25(2):136-137.
Research paper2022, jan 31

Degree of agreement between dacryoscintigraphy and dacryocystography examinations results in primary acquired nasolacrimal duct obstruction

Elyas Aditya, Yunia Irawati, Benny Zulkarnaien, Joedo Prihartono

Vol 25, No 1 (2022)

Research paper

Pubmed: 35137932
Nucl. Med. Rev 2022;25(1):12-17.
Research paper2023, may 2

Confirmation of PSMA expression measured on [68Ga]Ga-PSMA PET/CT by immunohistochemistry in prostate adenocarcinoma

Tarik Sengoz, Nilay Sen Turk, Yusuf Ozlulerden, Sinan Celen, Aziz Gultekin, Olga Yaylali, Dogangun Yuksel

Vol 26 (2023): Continuous Publishing

Research paper

Pubmed: 37381796
Nucl. Med. Rev 2023;26:68-73.
Review paper2022, jun 28

Myocardial perfusion imaging using single-photon emission computed tomography with cadmium-zinc-telluride technology

Sonia J. Konsek-Komorowska, Mariola Peczkowska, Jaroslaw B. Cwikła

Vol 25, No 2 (2022)

Review paper

Pubmed: 35848537
Nucl. Med. Rev 2022;25(2):119-126.
Guidelines / Expert consensus2022, jul 26

The scintigraphic diagnosis of cardiac amyloidosis. An expert opinion endorsed by the Section of Nuclear Medicine of the Polish Cardiac Society and the Polish Nuclear Medicine Society

Katarzyna Holcman, Miroslaw Dziuk, Jacek Grzybowski, Anna Teresinska, Bogdan Malkowski, Diana Jedrzejuk, Bogna Brockhuis, Rafał Czepczynski, Lidia Tomkiewicz-Pajak, Magdalena Kostkiewicz

Vol 25, No 2 (2022)

Guidelines / Expert consensus

Pubmed: 35929128
Nucl. Med. Rev 2022;25(2):142-147.
Research paper2023, oct 3

Performance of a deep learning enhancement method applied to PET images acquired with a reduced acquisition time

Krzysztof Ciborowski, Anna Gramek-Jedwabna, Monika Gołąb, Izabela Miechowicz, Jolanta Szczurek, Marek Ruchała, Rafał Czepczyński

Vol 26 (2023): Continuous Publishing

Research paper

Pubmed: 37786943
Nucl. Med. Rev 2023;26:116-122.
Clinical vignette2023, feb 16
Research paper2022, jan 31
Research paper2023, jul 11

Comparative analysis of different nuclear medicine techniques in evaluation of renal function

Aleksandra Peshevska, Tanja Makazlieva, Venjamin Majstorov, Lambe Barandovski, Irena Rambabova-Bushljetik, Daniela Miladinova

Vol 26 (2023): Continuous Publishing

Research paper

Pubmed: 37431648
Nucl. Med. Rev 2023;26:85-95.
Clinical vignette2022, jun 9

Radiopharmaceutical for detecting PSMA — positive metastatic colon cancer: Matched-pair comparison of 18F-BF3-Cy3-ACUPA and 68Ga-PSMA PET/MRI

Omer Aras, Cetin Demirdag, Harikrishna Kommidi, Richard Ting, Haluk B. Sayman

Vol 25, No 2 (2022)

Clinical vignette

Pubmed: 35699591
Nucl. Med. Rev 2022;25(2):129-130.
Clinical vignette2022, jan 20

Rare osteoarticular complications on [18F]FDG-PET/CT — following intravesical BCG immunotherapy for bladder cancer

Jan-Henning Schierz, Anke McLeod, Farzana Ali

Vol 25, No 1 (2022)

Clinical vignette

Pubmed: 35137942
Nucl. Med. Rev 2022;25(1):68-69.